2,094
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Comparative effectiveness of erythropoietin alpha and beta in hemodialysis patients: a single-center prospective observational study

, , , ORCID Icon, ORCID Icon, , & show all
Pages 782-786 | Received 30 Aug 2021, Accepted 17 Sep 2021, Published online: 15 Nov 2021

References

  • Horl WH. Differentiating factors between erythropoiesis-stimulating agents; An update to selection for anemia of chronic kidney disease. Drugs. 2013;73:117–130.
  • Ostrvica E, Mesic E, Ostrvica D, et al. Effectiveness of treating renal anemia in the chronic hemodialyzed patients by Epoetin alpha and beta. Med Arh. 2010;64(1):1–6.
  • Deicher R, Horl WH. Differentiating factors between erythropoiesis stimulating agents: a guide to selection for anemia of chronic kidney disease. Drugs. 2004;64(5):499–509.
  • Oka S, Obata Y, Torigoe K, et al. A comparative study of the hemoglobin-maintaining effects between epoetin beta- pegol and Darbepoetin- alpha in patient with chronic kidney disease during 3 months before dialysis initiation. Drugs RD. 2017;17:389–396.
  • Azmandian J, Abbasi MR, Pourfarziani V, et al. Comparing therapeutic efficacy and safety of Epoetin Beta and Epoetin Alpha in the treatment of anemia in end stage renal disease hemodialysis patients. Am J Nephrol. 2018;48:251–259.
  • Sinha SD, Bandi VK, Bheemareddy BR, et al. Efficacy, tolerability, and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase III trial. BMC Nephrol. 2019;20(19):1–9.
  • Carrera F, Burnier M. Use of darbepoetin alfa in the treatment of anemia of chronic kidney disease: clinical and pharmacoeconomic considerations. NDT Plus. 2009;2(1):9–17.
  • Locatelli F, Pozzoni P, Vecchio LD. Recombinant human epoetin beta in the treatment of renal anemia. Ther Clin Risk Manag. 2007;3(3):433–439.
  • Locatelli F, Covic A, Eckardt KU, et al. Anemia management in patients with chronic kidney disease: a position statement by the Anemia Working Group of European Renal Best Practice (ERBP). Nephrol Dialysis Transplantation. 2009;24(2):348–354.
  • Prasetya AANPR, Suprapti B, Shanti BD. Effectivity of erythropoietin alpha compared to erythropoietin beta in patients with chronic disease- anemia on hemodialysis. Fol Med Indones. 2019;55(2):82–88.
  • Loughnan A, Ali GR, Abeygunasekara SC. Comparison of the therapeutic efficacy of epoetin beta and epoetin alfa in maintenance phase hemodialysis patients. Ren Fail. 2011;33:373–375.